Author

H. Axemaker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Organism:human· 1

Frequent Co-Authors

K. Calar· 2 shared P. de la Puente· 2 shared S. Plesselova· 2 shared E. Sahly· 1 shared J. Wollman· 1 shared M. Jorgensen· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

K. Calar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multicompartmentalized microvascularized tumor-on-a-chip to study tumor-stroma interactions and drug resistance in ovarian cancer

S. Plesselova, K. Calar, H. Axemaker, E. Sahly, P. de la Puente

This paper develops a tumor-on-a-chip model to study ovarian cancer drug resistance by mimicking tumor-stroma interactions and compartmentalized microenvironment.

bioRxiv · May 29, 2024Bioengineering

Normal Uterine Fibroblast Are Reprogramed into Ovarian Cancer-Associated Fibroblasts by Ovarian Tumor-derived Conditioned Media

H. Axemaker, S. Plesselova, K. Calar, M. Jorgensen, J. Wollman, P. de la Puente

This study reprograms normal uterine fibroblasts into ovarian cancer-associated fibroblasts using ovarian tumor-derived conditioned media, demonstrating enhanced tumor progression and drug resistance.

bioRxiv · Sep 29, 2023 · PreprintCancer Biology